BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló S, Roda D, Huerta M, Cervantes A, Fleitas T. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat Rev 2020;86:102015. [PMID: 32248000 DOI: 10.1016/j.ctrv.2020.102015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan K, Wang Y, Lu Y, Yan Z. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome. J Immunol Res 2021;2021:6664791. [PMID: 33748290 DOI: 10.1155/2021/6664791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wei XL, Luo TQ, Li JN, Xue ZC, Wang Y, Zhang Y, Chen YB, Peng C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer. Front Mol Biosci 2021;8:691143. [PMID: 34277706 DOI: 10.3389/fmolb.2021.691143] [Reference Citation Analysis]
3 Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jia X, Guo T, Li Z, Zhang M, Feng Y, Dong B, Li Z, Hu Y, Li Z, Xing X, Jia S, Ji J. Clinicopathological and Immunomicroenvironment Characteristics of Epstein-Barr Virus-Associated Gastric Cancer in a Chinese Population. Front Oncol 2020;10:586752. [PMID: 33489884 DOI: 10.3389/fonc.2020.586752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sabbadini F, Bertolini M, Matteis S, De Mangiameli D, Contarelli S, Pietrobono S, Melisi D. The Multifaceted Role of TGF- β in Gastrointestinal Tumors.Cancers (Basel). 2021;13:3960. [DOI: 10.3390/cancers13163960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu CP, Li X, Lai GN, Li JH, Jia WY, Cao YY, Xu WX, Tan QL, Zhou CY, Luo M, Zhang XY, Yuan DQ, Tian JY, Zhang X, Zeng X. Mechanisms of Macrophage Immunomodulatory Activity Induced by a New Polysaccharide Isolated From Polyporus umbellatus (Pers.) Fries. Front Chem 2020;8:581. [PMID: 32850623 DOI: 10.3389/fchem.2020.00581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cui MY, Yi X, Zhu DX, Wu J. Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Transl Cancer Res 2021;10:3829-42. [PMID: 35116681 DOI: 10.21037/tcr-21-655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen Y, Zhang C, Peng Z, Qi C, Gong J, Zhang X, Li J, Shen L. Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor. Front Oncol 2021;11:589022. [PMID: 34141607 DOI: 10.3389/fonc.2021.589022] [Reference Citation Analysis]
9 Ma M, Sun J, Liu Z, Ouyang S, Zhang Z, Zeng Z, Li J, Kang W. The Immune Microenvironment in Gastric Cancer: Prognostic Prediction. Front Oncol 2022;12:836389. [PMID: 35574386 DOI: 10.3389/fonc.2022.836389] [Reference Citation Analysis]
10 Zhang F, Li X, Chen H, Guo J, Xiong Z, Yin S, Jin L, Chen X, Luo D, Tang H, Mao C, Lian L. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer. Front Med (Lausanne) 2022;9:836892. [PMID: 35211490 DOI: 10.3389/fmed.2022.836892] [Reference Citation Analysis]
11 Zhang C, Chong X, Jiang F, Gao J, Chen Y, Jia K, Fan M, Liu X, An J, Li J, Zhang X, Shen L. Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer. J Extracell Vesicles 2022;11:e12209. [PMID: 35362262 DOI: 10.1002/jev2.12209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang F, Chen C, Chen WP, Li ZL, Cheng H. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Biomed Res Int 2021;2021:6014202. [PMID: 34708125 DOI: 10.1155/2021/6014202] [Reference Citation Analysis]
13 Liang C, Fan J, Liang C, Guo J. Identification and Validation of a Pyroptosis-Related Prognostic Model for Gastric Cancer. Front Genet 2022;12:699503. [DOI: 10.3389/fgene.2021.699503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Li XY, Shi LX, Yao XM, Jing M, Li QQ, Wang YL, Li QS. Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer. Drug Dev Ind Pharm 2021;47:100-12. [PMID: 33295825 DOI: 10.1080/03639045.2020.1862169] [Reference Citation Analysis]
15 Mao D, Zhou Z, Song S, Li D, He Y, Wei Z, Zhang C. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer. Front Oncol 2021;11:626961. [PMID: 33747944 DOI: 10.3389/fonc.2021.626961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Navashenaq JG, Shabgah AG, Banach M, Jamialahmadi T, Penson PE, Johnston TP, Sahebkar A. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol 2021:S1044-579X(21)00248-0. [PMID: 34600095 DOI: 10.1016/j.semcancer.2021.09.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gao J, Huo S, Zhang Y, Zhao Z, Pan H, Liu X. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients. Cancer Med 2022. [PMID: 35621244 DOI: 10.1002/cam4.4857] [Reference Citation Analysis]
18 Pawłowska A, Kwiatkowska A, Suszczyk D, Chudzik A, Tarkowski R, Barczyński B, Kotarski J, Wertel I. Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients. Int J Mol Sci 2021;22:11563. [PMID: 34768993 DOI: 10.3390/ijms222111563] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cui X, Qin T, Zhao Z, Yang G, Sanches JGP, Zhang Q, Fan S, Cao L, Hu X. Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization. J Cancer 2021;12:4686-97. [PMID: 34149932 DOI: 10.7150/jca.58698] [Reference Citation Analysis]
20 Becerril-Rico J, Alvarado-Ortiz E, Toledo-Guzmán ME, Pelayo R, Ortiz-Sánchez E. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor. Stem Cell Res Ther 2021;12:498. [PMID: 34503571 DOI: 10.1186/s13287-021-02562-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Wang DK, Zuo Q, He QY, Li B. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Front Immunol 2021;12:705999. [PMID: 34447376 DOI: 10.3389/fimmu.2021.705999] [Reference Citation Analysis]
22 Qu J, Luo M, Zhang J, Han F, Hou N, Pan R, Sun X. A paradoxical role for sestrin 2 protein in tumor suppression and tumorigenesis. Cancer Cell Int 2021;21:606. [PMID: 34784907 DOI: 10.1186/s12935-021-02317-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zheng L, Xu H, Di Y, Chen L, Liu J, Kang L, Gao L. ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis. J Transl Med 2021;19:342. [PMID: 34372882 DOI: 10.1186/s12967-021-02915-1] [Reference Citation Analysis]
25 Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Santos Marques H, de Brito BB, França da Silva FA, Souza CL, Oliveira MV, de Melo FF. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. World J Clin Oncol 2022; 13(3): 186-199 [DOI: 10.5306/wjco.v13.i3.186] [Reference Citation Analysis]
26 Wang M, Li C, Liu Y, Wang Z. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer. Biomed Res Int 2021;2021:6428873. [PMID: 34414238 DOI: 10.1155/2021/6428873] [Reference Citation Analysis]
27 Zhou LQ, Shen JX, Zhou JY, Hu Y, Xiao HJ. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database. Sci Rep 2022;12:579. [PMID: 35022464 DOI: 10.1038/s41598-021-04591-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Guan X, Xu ZY, Chen R, Qin JJ, Cheng XD. Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients. Front Oncol 2020;10:629909. [PMID: 33628738 DOI: 10.3389/fonc.2020.629909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gan Z, Zhang M, Xie D, Wu X, Hong C, Fu J, Fan L, Wang S, Han S. Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases. Front Immunol 2021;12:762564. [PMID: 34675940 DOI: 10.3389/fimmu.2021.762564] [Reference Citation Analysis]
30 Gu R, Xia Y, Li P, Zou D, Lu K, Ren L, Zhang H, Sun Z. Ferroptosis and its Role in Gastric Cancer. Front Cell Dev Biol 2022;10:860344. [DOI: 10.3389/fcell.2022.860344] [Reference Citation Analysis]
31 Liu T, Zhang J, Chen H, Bianba T, Pan Y, Wang X, Jiang Y, Yang Z. PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway. Oncogenesis 2022;11. [DOI: 10.1038/s41389-022-00386-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Song S, Shu P. Expression of ferroptosis-related gene correlates with immune microenvironment and predicts prognosis in gastric cancer. Sci Rep 2022;12:8785. [PMID: 35610340 DOI: 10.1038/s41598-022-12800-6] [Reference Citation Analysis]
33 Liu M, Zhang L, Zhou Q, Wang Y, Sun Q, Ren X. The Distinct Impact of TAM Infiltration on the Prognosis of Patients With Cardia and Non-Cardia Gastric Cancer and Its Association With H. pylori Infection. Front Oncol 2021;11:737061. [PMID: 34926251 DOI: 10.3389/fonc.2021.737061] [Reference Citation Analysis]
34 Zhang Y, Wang H, Xu X, Liu H, Hao T, Yin S, Zhang C, He Y. Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients. Front Oncol 2021;11:668707. [PMID: 34485116 DOI: 10.3389/fonc.2021.668707] [Reference Citation Analysis]
35 Wei Y, Zhang J, Fan X, Zheng Z, Jiang X, Chen D, Lu Y, Li Y, Wang M, Hu M, Du Q, Yang L, Li H, Xiao Y, Li Y, Jin J, Wang D, Yuan X, Li Q. Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression. Front Immunol 2022;13:935552. [DOI: 10.3389/fimmu.2022.935552] [Reference Citation Analysis]
36 Zhao B, Zhu W. Exosomal miRNA-455 from Bone Marrow Stromal Cells (BMSCs) Promotes Macrophage Phagocytosis and Restrains Progression of Gastric Cancer (GC). j biomater tissue eng 2022;12:558-63. [DOI: 10.1166/jbt.2022.2939] [Reference Citation Analysis]
37 Qiu X, Zhao T, Luo R, Qiu R, Li Z. Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front Oncol 2022;12:772615. [DOI: 10.3389/fonc.2022.772615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Lin T, Peng W, Mai P, Zhang E, Peng L. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer. Front Mol Biosci 2021;8:626966. [PMID: 34113647 DOI: 10.3389/fmolb.2021.626966] [Reference Citation Analysis]
39 Lodewijk I, Nunes SP, Henrique R, Jerónimo C, Dueñas M, Paramio JM. Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy. Clin Epigenetics 2021;13:63. [PMID: 33761971 DOI: 10.1186/s13148-021-01046-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zheng P, Li W. Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer. Front Oncol 2020;10:571516. [PMID: 33163402 DOI: 10.3389/fonc.2020.571516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Han C, Zhang C, Wang H, Zhao L. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. Oncoimmunology 2021;10:1887552. [PMID: 33680573 DOI: 10.1080/2162402X.2021.1887552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
42 Cao Y, Tu Y, Xiong J, Tan S, Luo L, Wu A, Shu X, Jie Z, Li Z. microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription. J Exp Clin Cancer Res 2022;41:152. [PMID: 35449111 DOI: 10.1186/s13046-022-02356-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rojas A, Lindner C, Schneider I, Gonzàlez I, Araya H, Morales E, Gómez M, Urdaneta N, Araya P, Morales MA. Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer. World J Gastrointest Oncol 2021;13:1997-2012. [PMID: 35070037 DOI: 10.4251/wjgo.v13.i12.1997] [Reference Citation Analysis]
44 Zhao L, Liu Y, Zhang S, Wei L, Cheng H, Wang J, Wang J. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Cell Death Dis 2022;13:378. [PMID: 35444235 DOI: 10.1038/s41419-022-04821-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Miyamoto S, Tanaka T, Hirosuna K, Nishie R, Ueda S, Hashida S, Terada S, Konishi H, Kogata Y, Taniguchi K, Komura K, Ohmichi M. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization. Cancers (Basel) 2022;14:2969. [PMID: 35740635 DOI: 10.3390/cancers14122969] [Reference Citation Analysis]
46 Bahrami M, Haji Molla Hoseini M, Rezaei M, Ziai SA. Umbelliprenin Increases the M1/M2 Ratio of Macrophage Polarization and Improves the M1 Macrophage Activity in THP-1 Cells Cocultured with AGS Cells. Evid Based Complement Alternat Med 2021;2021:9927747. [PMID: 34335844 DOI: 10.1155/2021/9927747] [Reference Citation Analysis]
47 Yu X, He S, Shen J, Huang Q, Yang P, Huang L, Pu D, Wang L, Li L, Liu J, Liu Z, Zhu L. Tumor vessel normalization and immunotherapy in gastric cancer. Ther Adv Med Oncol 2022;14:17588359221110176. [PMID: 35872968 DOI: 10.1177/17588359221110176] [Reference Citation Analysis]
48 Fu X, Li J, Li X, Tan Y, Zhao M, Zhang S, Wu X, Xu J, Wang F. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway. Journal of Immunology Research 2022;2022:1-20. [DOI: 10.1155/2022/8326591] [Reference Citation Analysis]
49 Petrillo A, Smyth EC. Biomarkers for Precision Treatment in Gastric Cancer. Visc Med 2020;36:364-72. [PMID: 33178733 DOI: 10.1159/000510489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
50 Mao D, Xu R, Chen H, Chen X, Li D, Song S, He Y, Wei Z, Zhang C. Cross-Talk of Focal Adhesion-Related Gene Defines Prognosis and the Immune Microenvironment in Gastric Cancer. Front Cell Dev Biol 2021;9:716461. [PMID: 34660578 DOI: 10.3389/fcell.2021.716461] [Reference Citation Analysis]
51 Fathi M, Pustokhina I, Kuznetsov SV, Khayrullin M, Hojjat-Farsangi M, Karpisheh V, Jalili A, Jadidi-Niaragh F. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. IUBMB Life 2021;73:726-38. [PMID: 33686787 DOI: 10.1002/iub.2461] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Tincknell G, Piper AK, Aghmesheh M, Becker T, Vine KL, Brungs D, Ranson M. Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma. Cancers (Basel) 2021;13:4097. [PMID: 34439251 DOI: 10.3390/cancers13164097] [Reference Citation Analysis]
53 Xu X, Lu Y, Wu Y, Wang M, Wang X, Wang H, Chen B, Li Y. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients. Cancer Cell Int 2021;21:117. [PMID: 33602220 DOI: 10.1186/s12935-021-01823-0] [Reference Citation Analysis]
54 Fang F, Zhang T, Li Q, Chen X, Jiang F, Shen X. The tumor immune-microenvironment in gastric cancer. Tumori 2022;:3008916211070051. [PMID: 35196917 DOI: 10.1177/03008916211070051] [Reference Citation Analysis]
55 Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J Clin Med 2021;10:1412. [PMID: 33915839 DOI: 10.3390/jcm10071412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S. Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses. Front Immunol 2022;13:923477. [DOI: 10.3389/fimmu.2022.923477] [Reference Citation Analysis]
57 Li Y, Zhong X, Zhang Y, Lu X. Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful. Front Oncol 2021;11:617677. [PMID: 34046337 DOI: 10.3389/fonc.2021.617677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Yu H, Bai Y, Qiu J, He X, Xiong J, Dai Q, Wang X, Li Y, Sheng H, Xin R, Jiang L, Li Q, Li D, Zhang H, Zhang L, Chen Q, Peng J, Hu X, Zhang K. Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit. Front Oncol 2021;11:736882. [PMID: 34900687 DOI: 10.3389/fonc.2021.736882] [Reference Citation Analysis]
59 Zhao R, Wan Q, Wang Y, Wu Y, Xiao S, Li Q, Shen X, Zhuang W, Zhou Y, Xia L, Song Y, Chen Y, Yang H, Wu X. M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer. Oncoimmunology 2020;10:1862520. [PMID: 33457080 DOI: 10.1080/2162402X.2020.1862520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
60 Chen T, Yang C, Dou R, Xiong B. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer. Cancer Med 2021. [PMID: 34382341 DOI: 10.1002/cam4.4180] [Reference Citation Analysis]
61 Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, Pan Z, Guo Q, Li B, Zhao S, Guo X, Qian M, Chen Z, Wang S, Gao X, Zhang S, Wang H, Guo X, Zhang P, Zhao R, Xue H, Li G. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis 2021;12:373. [PMID: 33828078 DOI: 10.1038/s41419-021-03664-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Lyu Z, Li Y, Zhu D, Wu S, Hu F, Zhang Y, Li Y, Hou T. Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma. Front Cell Dev Biol 2022;10:859999. [DOI: 10.3389/fcell.2022.859999] [Reference Citation Analysis]
63 Niu X, Ren L, Wang S, Gao D, Ma M, Hu A, Qi H, Zhang S. High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer. Front Genet 2022;13:952335. [DOI: 10.3389/fgene.2022.952335] [Reference Citation Analysis]
64 Chen S, Su X, Wang J, Zheng N, Tang Y, Peng G, Dong R, Lu F, Liu M, Zhao Y, Wu H. Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis. Front Oncol 2022;12:935239. [DOI: 10.3389/fonc.2022.935239] [Reference Citation Analysis]
65 Cheng Y, Song S, Wu P, Lyu B, Qin M, Sun Y, Sun A, Mu L, Xu F, Zhang L, Wang J, Zhang Q. Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines. Adv Healthc Mater 2021;10:e2100590. [PMID: 34292673 DOI: 10.1002/adhm.202100590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
66 Smyth EC, Gambardella V, Cervantes A, Fleitas T. Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy. Ann Oncol 2021;32:590-9. [PMID: 33609722 DOI: 10.1016/j.annonc.2021.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
67 Yang Y, Meng WJ, Wang ZQ. Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer. Front Oncol 2021;11:803974. [PMID: 35047411 DOI: 10.3389/fonc.2021.803974] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 He F, Ding H, Zhou Y, Wang Y, Xie J, Yang S, Zhu Y. Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer. Front Med (Lausanne) 2021;8:792740. [PMID: 35178409 DOI: 10.3389/fmed.2021.792740] [Reference Citation Analysis]
69 Li Q, Wu W, Gong D, Shang R, Wang J, Yu H. Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling. Gastric Cancer 2021. [PMID: 34076786 DOI: 10.1007/s10120-021-01202-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Jiang X, Gao Y, Zhang N, Yuan C, Luo Y, Sun W, Zhang J, Ren J, Gong Y, Xie C. Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis. Cell Transplant 2020;29:963689720977131. [PMID: 33334139 DOI: 10.1177/0963689720977131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Yang KS, Xu CQ, Lv J. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Bioengineered 2021;12:1238-50. [PMID: 33843442 DOI: 10.1080/21655979.2021.1911557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Lu L, Liu YJ, Cheng PQ, Hu D, Xu HC, Ji G. Macrophages play a role in inflammatory transformation of colorectal cancer. World J Gastrointest Oncol 2021; 13(12): 2013-2028 [DOI: 10.4251/wjgo.v13.i12.2013] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Huang M, Peng X, Yang L, Yang S, Li X, Tang S, Li B, Jin H, Wu B, Liu J, Li H. Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications. Cancer Lett 2021;501:234-46. [PMID: 33186654 DOI: 10.1016/j.canlet.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ieni A, Caruso RA, Pizzimenti C, Giuffrè G, Irato E, Rigoli L, Navarra G, Fadda G, Tuccari G. M1 Polarized Tumor-Associated Macrophages (TAMs) as Promising Prognostic Signature in Stage I–II Gastric Adenocarcinomas. GastrointestDisord 2021;3:207-17. [DOI: 10.3390/gidisord3040020] [Reference Citation Analysis]
75 Huang X, Zhang J, Zheng Y. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer. Front Mol Biosci 2020;7:598221. [PMID: 33385012 DOI: 10.3389/fmolb.2020.598221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]